Product Description

CANMAB 150 MG Injection Vial contains Trastuzumab 150 mg, a targeted monoclonal antibody used in the treatment of certain HER2 positive cancers. It targets the HER2 protein involved in the growth and survival of certain cancer cells. Treatment should be administered under the supervision of a qualified oncology specialist.

🔹 Key Uses
Treatment of HER2 positive breast cancer
Treatment of HER2 positive metastatic breast cancer
Treatment of HER2 positive gastric or gastroesophageal junction cancer
May be used in other HER2 positive cancers according to the oncology treatment plan

🔹 Composition
Trastuzumab 150 mg

🔹 How It Works
Trastuzumab binds to the HER2 protein present on certain cancer cells. This can block HER2 signaling involved in cancer cell growth and may also help the immune system recognize and destroy HER2 positive cancer cells.

🔹 Key Benefits
Provides targeted treatment for HER2 positive cancers
Helps inhibit HER2 mediated cancer cell growth
May be used alone or with chemotherapy or other anticancer medicines depending on the treatment plan

🔹 Dosage and Administration
The dose and treatment schedule must be determined by the oncology specialist based on the type and stage of cancer, body weight, treatment protocol, and overall health. CANMAB 150 MG Injection is administered by intravenous infusion by trained healthcare professionals.

🔹 Possible Side Effects
Fever
Chills
Headache
Nausea
Diarrhea
Fatigue
Infusion related reactions
Low blood cell counts
Infections
Heart related problems

🔹 Precautions and Warnings
CANMAB 150 MG Injection should be used only under the supervision of a qualified oncology specialist.
Trastuzumab can affect heart function. Heart function may need to be assessed before and during treatment.
Infusion related reactions may occur during or shortly after administration. Patients should be monitored during the infusion.
Inform the doctor about existing heart disease, breathing problems, or previous treatment with medicines that may affect the heart.
Inform the doctor about all medicines and anticancer treatments being used.
Pregnancy should be avoided during treatment because trastuzumab may harm an unborn baby. Effective contraception should be discussed with the doctor.

Seek immediate medical attention for severe breathing difficulty, chest discomfort, severe allergic reactions, or other serious symptoms during or after infusion.